Overview
HOMA-IR is not a test you order. It is a calculation made from two tests you already have — fasting glucose and fasting insulin — that estimates how insulin-resistant you are. Its value is that it collapses two numbers that only make sense together into one you can actually follow over time.
Its limitation is that it was designed as a research tool for comparing populations, not as a clinical threshold for individuals. Both halves of that matter.
| What it does well | What it does not do | |
|---|---|---|
| HOMA-IR | Combines glucose and insulin into one trackable index. Sensitive to change over months. Cheap, since it uses tests you already ran | Diagnose anything. It is not a guideline criterion for diabetes or prediabetes |
| Fasting glucose | Diagnostic criterion. Simple, standardized | Moves late — often normal for years while compensation happens |
| HbA1c | Diagnostic criterion. Averages three months, no fasting needed | Also late. Distorted by anemia and altered red cell turnover |
| Fasting insulin alone | Moves early | Hard to interpret without the glucose it was working against |
| Oral glucose tolerance test | More informative about the dynamic response | Time-consuming, less pleasant, rarely used outside pregnancy and specific cases |
How it is calculated
The standard formula multiplies fasting insulin by fasting glucose and divides by a constant — 405 when glucose is in mg/dL, 22.5 when it is in mmol/L.
The logic is simple. If your glucose is normal because your insulin is high, the product of the two captures that in a way neither number does alone. A person holding a normal glucose on modest insulin and a person holding the same glucose on a great deal of insulin end up with visibly different values.
Two practical consequences follow. The sample must be genuinely fasting — 8 to 12 hours — because both inputs move with food. And the units matter: a HOMA-IR figure calculated from mg/dL is not comparable to one from mmol/L unless the right constant was used. If you are comparing a result to something you read online, check which unit it assumed.
Where the thresholds sit, and why we are careful about them
Various cut-offs circulate — you will see numbers quoted as the point above which someone is "insulin resistant."
We are deliberately not going to print one as though it were settled, for three reasons.
The thresholds are population-derived and vary by population, differing by ethnicity, age and the reference group a given study used.
Insulin assays are not standardized between laboratories. Because insulin is one of the two inputs, a HOMA-IR from one laboratory is not directly comparable to one from another. This is the single biggest practical limitation and it is rarely mentioned.
It was built for research. HOMA-IR was developed to compare groups in studies, not to categorize individuals in clinic. It has been widely adopted clinically because it is cheap and convenient, which are good reasons — but they are not the same as being validated as a diagnostic threshold.
So the honest position is that HOMA-IR is far more useful as a trend than as a verdict. Your own value now versus your value nine months ago, from the same laboratory, tells you something genuinely useful. Your value against a number from an article tells you rather less.
Where it falls down completely
There is one situation where HOMA-IR stops working, and it is important: it assumes your pancreas is still compensating.
In someone whose insulin production has begun to fail — later-stage type 2 diabetes, or type 1 — insulin falls while glucose rises. HOMA-IR can then come back deceptively reassuring at exactly the point the person is least well. It is a marker for the compensating phase, not for the whole spectrum.
It is also unreliable in pregnancy, in significant liver or kidney disease, and in anyone on insulin therapy, where the measured insulin is not their own.
What actually moves it
The interventions with the best evidence are unglamorous and effective.
Resistance training, because muscle is where most post-meal glucose goes, and more trained muscle means more capacity to take it up. This is the lever most often underused in midlife and the one we would put first.
Movement after meals — even a short walk — measurably blunts the glucose excursion.
Sleep. Short-term sleep restriction reduces insulin sensitivity in healthy people within days, which is one reason untreated sleep-disordered breathing undermines metabolic treatment.
Losing visceral fat specifically, which responds better and matters more than total weight.
Reducing alcohol, which contributes both directly and through disrupted sleep.
Where medication has a role, that is a clinical decision made on the full picture. At the compensating stage, in most people, the training and sleep levers have the better evidence and the fewer trade-offs.
Frequently asked questions
Is HOMA-IR a diagnosis? No. Diabetes and prediabetes are defined on glucose criteria — fasting glucose, HbA1c or a glucose tolerance test. HOMA-IR is an index that helps you see earlier, not a diagnostic threshold.
What is a good HOMA-IR? Lower generally reflects better insulin sensitivity, and we would rather not print a threshold as though it were fixed — the cut-offs vary by population and insulin assays are not standardized between laboratories. Your own trend from the same lab is the more useful comparison.
Can I calculate it myself from my results? Yes, if you have fasting glucose and fasting insulin from the same fasted sample and you use the constant matching your glucose units. What it means is the part worth discussing with a clinician.
How often should it be re-checked? It moves over months, not weeks. Annually, or after a genuine change in training, sleep, weight or medication, is more informative than frequent repeats.
My HOMA-IR is fine but my waist is growing. Which do I trust? Both, and the waist is not nothing. HOMA-IR is one input. Waist circumference, triglycerides, HDL and blood pressure together form a picture that no single index replaces.
Where this fits in your plan
HOMA-IR is a useful way to make two results speak to each other, and a poor way to categorize yourself against a number from the internet.
It belongs on a panel that already includes fasting insulin, glucose, HbA1c and a full lipid picture — and it earns its keep when you run it again nine months later and see which way things have moved.
We measure first. Then we act.
Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.
Ready to start your second act?
It starts with measuring, not guessing. A short, clinician-reviewed assessment shows what fits you.
This article is educational and is not medical advice. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. Individual results vary.
